Protalix BioTherapeutics (PLX) Work In Process (2012 - 2026)

Protalix BioTherapeutics' Work In Process history runs 9 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• In Q1 2026, Work In Process rose 13.51% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $9.1 million (up 13.51% YoY), while the FY2025 annual figure was $9.4 million, down 16.63% from the prior year.
• Work In Process was $9.1 million for Q1 2026 at Protalix BioTherapeutics, down from $9.4 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $12.3 million in Q3 2024 to a low of $1.5 million in Q1 2023.
• Historically, Work In Process has averaged $7.0 million across 5 years, with a median of $8.1 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Work In Process jumped 498.11% in 2024, then sank 56.29% in 2025.
• A 5-year view of Work In Process shows it stood at $2.7 million in 2022, then surged by 238.13% to $9.1 million in 2023, then grew by 24.19% to $11.2 million in 2024, then declined by 16.63% to $9.4 million in 2025, then declined by 3.11% to $9.1 million in 2026.
• The last three Work In Process figures came in at $9.1 million (Q1 2026), $9.4 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.